Importantly, activation of cGAS-STING pathway by STINGa in Herceptin-resistant BC could reverse IFN signaling activity, which promotes anti-tumor immune response and have a synergistic anti-tumor effect with DS-8201 in vitro and in vivo. Here, CGAS is linked to neoplasm.